Search
Close this search box.

October 21, 2024

Angelini Pharma Enters Into An Exclusive Option Agreement With Cureverse to License Global Development and Commercialization Rights For A Novel and Innovative Clinical-Stage Brain Health Asset

The agreement gives Angelini Pharma an option to exclusive licensing rights to develop and commercialize CV-011, a clinical Phase 1 investigational novel compound with broad potential to treat brain health diseases Cureverse receives undisclosed upfront payments and is eligible for

Read More ➜

Minimal cut on pump prices set Oct. 22

Manila: After three straight weeks of price hikes, oil firms will cut pump prices effective Tuesday. In separate advisories on Monday, Caltex, Cleanfuel, Petro Gazz, Seaoil, and Shell said they will roll back gasoline prices by 50 centavos per liter,

Read More ➜

Recent News